Synthetic Lethality Nanoparticles Kill Difficult to Treat Cancers

Researchers at the University of Iowa have developed dual-action nanoparticles that have been shown, in a laboratory study, to selectively kill endometrial cancer (uterine serous carcinoma) cells. The therapeutic approach combines paclitaxel, a commo...
Source: Medgadget - Category: Medical Devices Authors: Tags: Nanomedicine Oncology Source Type: blogs